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Cardiac autonomic dysfunction in
patients with schizophrenia and their
healthy relatives – a small review
Karl-Jürgen Bär*
Psychiatric Brain and Body Research Group Jena, Department of Psychiatry and Psychotherapy, University Hospital,
Friedrich-Schiller-University, Jena, Germany
The majority of excess mortality among people with schizophrenia seems to be caused
by cardiovascular complications, and in particular, coronary heart disease. In addition,
the prevalence of heart failure and arrhythmias is increased in this population. Reduced
efferent vagal activity, which has been consistently described in these patients and
their healthy first-degree relatives, might be one important mechanism contributing to
their increased cardiac mortality. A decrease in heart rate variability and complexity
was often shown in unmedicated patients when compared to healthy controls. In
addition, faster breathing rates, accompanied by shallow breathing, seem to influence
autonomic cardiac functioning in acute unmedicated patients substantially. Moreover,
low-physical fitness is a further and independent cardiac risk factor present in this
patient population. Interestingly, new studies describe chronotropic incompetence during
physical exercise as an important additional risk factor in patients with schizophrenia.
Some studies report a correlation of the autonomic imbalance with the degree of positive
symptoms (i.e., delusions) and some with the duration of disease. The main body of
psychiatric research is focused on mental aspects of the disease, thereby neglecting
obvious physical health needs of these patients. Here, a joint effort is needed to design
interventional strategies in everyday clinical settings to improve physical health and quality
of life.
Keywords: continuous training, heart rate variability, exercise intervention, sudden cardiac death, autonomic
dysfunction
Background
A large body of evidence has documented shortened life expectancy in patients with schizophrenia
(1–4). It has been assumed that suicides, accidents, and cardiovascular disorders are themain reasons
for the excess of premature and sudden deaths among patients with schizophrenia (3–6). In patients
treatedwith antipsychotics, research showed evidence that the incidence-rate ratio of sudden cardiac
death (SCD) was doubled in individuals receiving first- or second-generation antipsychotics in the
last month of life (7). The dose-dependent effect of antipsychotics on myocardial cell repolarization
was assumed to lead to torsades de pointes, arrhythmias, and, finally, to ventricular fibrillation
and SCD. In this line of evidence, a recent study reporting autopsy findings in inpatients with
schizophrenia showed that cardiovascular disorders were the most common cause of death (8).
Thus, schizophrenia may represent a disorder with a specific cardiac vulnerability to SCD (9).
This assumption is supported by a recent study by Mothi et al. (10) showing that cardiovascular
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and metabolic dysfunction is increased in healthy first-degree
relatives of patients. This is very suggestive of an overlapping
genetic background of cardiac/metabolic conditions and psy-
chotic disorders.
Sudden cardiac death happens when a malignant arrhythmia
is triggered by an acute cardiac event (e.g., acute myocardial
ischemia, platelet activation, or neuroendocrine variations) on
the basis of a diseased myocardium (e.g., post-necrotic scar or
hypertrophy). In addition to coronary artery disease or diseases
of the myocardium, cardiac electrophysiological abnormalities
might predispose to the development of ventricular fibrillation.
This is especially important after acute myocardial infarction
(AMI). Physicians found that various indices of heart rate vari-
ability (HRV) are of predictive value for the outcome of patients
after AMI. Subsequently, these measures were transferred to other
patient populations. Abnormalities were found for patients suf-
fering from depression, anxiety disorders, alcohol dependence,
and, in particular, patients suffering from schizophrenia (11–
16). The main difference, however, is the significance of these
values. After AMI, the risk prediction of HRV values for SCD is
defined by a measurable endpoint (death). By contrast, the exact
meaning of reduced HRV measures in mental disorders is more
difficult to define, since patients live with the disease and altered
cardiac autonomic function formany years. Therefore, the definite
influence of profound autonomic dysfunction in patients with
schizophrenia for reduced life expectancy needs to be shown in
long-term prospective studies.
Heart Rate Variability
The term HRV refers to a number of measures of different
types. In general, nearly all HRV measures reflect mainly vagal
(parasympathetic) modulation at the level of the heart. HRV is
the physiological phenomenon of variation in the time interval
between heart beats and it is determined by measuring the vari-
ation in the beat-to-beat interval (BBI). Although HRV measures
can be obtained quite easily nowadays, there are numerous pitfalls.
Autonomic indices depend very much on circadian rhythms,
the duration and measurement procedure, the environment, and
the artifact management. Time domain and frequency domain
measures are most often used. In general, if time domain mea-
sures [e.g., root mean square successive difference (RMSSD)]
are extremely low, true autonomic dysfunction can be assumed.
Frequency domain measures [e.g., high frequency (HF), low fre-
quency (LF), very low frequency (VLF)], which are very suscep-
tible to artifacts, quantify the amount of variance in heart rate at
different underlying frequencies. Again, extremely low values of
HF are associated with a lack of autonomic vagal modulation of
heart rate.
Besides linear HRV parameters describing the variance of BBIs,
non-linear complexity measures have been developed to describe
the regularity of heart rate time series. The application of these
novel analyses has led to a higher sensitivity for detecting auto-
nomic dysfunction (17, 18) and patients at risk for sudden death
(19). A high complexity of biosignals reflects diverse influences
of different regulatory systems. In the case of BBI, these are,
among others, neuronal (autonomic nervous system), hormonal
(e.g., cortisol, ANP), andmyocardium inherent mechanisms (20).
Overall, up to a certain point, the more irregular and complex
heart rate series are the more adaptive and stable is the underlying
system. Such complexity is only in part reflected in measures
of classical moment statistics such as means and SEs (e.g., time
domain or frequency domain measures), which mainly describe
the fluctuation of the biosignal. However, classical parameters do
not contain sufficient information on the regularity pattern of
these fluctuations. For example, a sine curve might have the same
mean and SE as a very irregularly shaped curve, which is why non-
linear measures are required to detect these differences in system
complexity.
Heart Rates of Unmedicated Patients
Suffering from Schizophrenia
“Taking the pulse” has always been the first point of contact
between physicians and the patient. It has recently been suggested
that the heart rate corresponds to the rate of energy needed
by the body. A reduction in heart rate of 10 bpm a day saves
5 kg of adenosintriphosphate (ATP). Furthermore, an increase
in heart rate of 5 bpm corresponds to a significant increase in
the atherosclerosis progression. Animal and human studies show
that life expectancy is closely related to the medium heart rate.
Increased resting heart rate has been shown to be a risk factor for
reduced life expectancy in both the general population (21, 22)
and in populations with cardiovascular diseases (23, 24).
In 1899, Emil Kraepelin described extensive autonomic alter-
ations in patients with schizophrenia, including increased heart
rates, altered pupillary function, increased sweating and saliva-
tion, as well as temperature changes (25). Most of these described
signs suggest increased sympathetic output, decreased parasym-
pathetic modulation, or both. For a long time, psychiatrists
attributed increased heart rates in patients with schizophrenia
to antipsychotic treatment. This assumption is only to some
extent correct. Treatment with clozapine, for instance, is asso-
ciated with reduced vagal function and increased heart rates
(26–28). However, several studies have reported increased heart
rates in first episode and unmedicated patients (26, 29–31).
In a pooled analysis, we found that among 119 unmedicated
patients the heart rate at rest was increased by about 10 bpm in
over 40% of patients and by about 20 bpm in 25% of patients
(unpublished data). It is important to understand that antipsy-
chotic drugs might increase heart rates due to anticholinergic
side effects even further (32). Here, a dose-dependent increase
has been described (28). However, other authors have found
improved autonomic function after the introduction of antipsy-
chotic treatment, possibly due to changes in clinical presentation
(33) or only minor effects of treatment on cardiac autonomic
function (34).
Investigations in healthy first-degree relatives of patients dis-
played similarly increased heart rates although less pronounced
(35–39). Comparable to other findings such as structural brain
changes in healthy relatives of patients with schizophrenia (40)
autonomic dysfunction seems to have a genetic basis. A summary
of investigates autonomic domains in patients and their healthy
relatives is shown in Figure 1.
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FIGURE 1 | The figure shows investigated autonomic domains in patients with schizophrenia and their healthy first-degree relatives. Peak heart rates
indicate heart rates during vigorous exercises. Tachygastria is a sympathetic parameter obtained in the electrogastrogramm.
Time and Frequency Domain Parameters
of HRV in Patients with Schizophrenia
As described above, HRV is the beat-to-beat oscillation of RR
intervals around its mean value. It is the result of complex
regulatory mechanisms through which the autonomic nervous
system influences heart rate and keeps cardiovascular parameters
within physiological health ranges.
Both time and frequency domain parameters of HRV show
reduced efferent vagal activity in unmedicated patients (29, 32, 36,
41–44). Described results were obtained by short time measure-
ments (5 and 30min) aswell as by 24-h holter ECGmeasurements.
This effect cannot be explained by increased heart rates alone, nor
is it solely allegeable by sympathetic modulation.
Complexity Measures of Heart Rate in
Patients with Schizophrenia
A concept that is closely connected to that of variability is com-
plexity. It is important to realize that complexity is different from
variability and there is no simple definition for it. A time series
might show high variability and very low complexity. “Simple”
time series are readily understood, and can be described concisely
as having low information content or low complexity. Conversely,
complex series are not easy to understand completely, they are
full of unforeseeable shifting and require lengthy descriptions,
making their information content high. Complex signals pro-
duced by healthy organisms might have dynamic properties such
as non-linearity (the relationships among components are not
additive, so small perturbations can cause large effects) or non-
stationarity (statistical properties of the system’s output change
with time). Thus, high complexity describes to a certain degree
healthy physiological properties, while low complexity describes
reduced influence of various regulatory circuits. Vice versa, the
more irregular and complex heart rate series are the more adap-
tive and stable is the underlying system. Such complexity is
only in part reflected in measures of classical moment statis-
tics such as means and SEs, which mainly describe the fluctu-
ation of a biosignal (45). Since no single measure is sufficient
to capture the properties of the most complex signals, differ-
ent complexity measures are needed. For heart rate in patients
with schizophrenia, we have mainly used compression entropy
(17), measures of symbolic dynamics (19, 46), and approximate
entropy (47).
To give an example of the calculation of complexity mea-
sures, compression entropy (Hc) is described below: the entropy
(complexity) of a given text is defined in terms of the smallest
algorithm that is capable of generating the text. Although it is
theoretically impossible to develop such an algorithm, data com-
pressors represent a sufficient approximation. The LZ77 algorithm
for loss-less data compression introduced by Ziv and Lempel
(48) is widely used and implemented in many file compres-
sors such as Winzip®. Its application in RR time series has been
described by Baumert et al. (17). The ratio of the compressed
to the original time series length represents an index of entropy
and is referred to as compression entropy Hc. Thus, compres-
sion entropy indicates the degree to which data from heart rate
time series can be compressed using the detection of recurring
sequences. The more frequent certain sequences occur – and
therefore, the more regular these series are – the higher the
compression rate.
Similarly to variability parameters, various studies during the
last years have described reduced complexity of heart rate dynam-
ics in patients with schizophrenia (32, 42, 49–52). The reduction
in complexity indicates that in patients with schizophrenia, the
heart rate cannot adapt to different requirements arising from
posture or exertion and that the heart is at higher risk of devel-
oping arrhythmias. In addition, one can speculate that reduced
regulatory influence from the vagal system might contribute to
reduced complexity. It is a method-inherent problem that com-
plexity measures cannot be attributed to one single physiological
system.
Baroreflex Sensitivity
The evaluation of baroreflex sensitivity (BRS) is an established
tool for the assessment of autonomic control of the cardiovascular
system. The baroreflex or baroreceptor reflex is one of the body’s
homeostatic mechanisms to maintain blood pressure at nearly
constant levels. The baroreflex provides a negative feedback loop
in which an elevated blood pressure reflexively causes the heart
rate to decrease. By contrast, diminished blood pressure reduces
baroreflex activation and causes heart rate to increase. A reduction
in baroreflex control of heart rate has been reported in hyper-
tension, coronary artery disease, myocardial infarction, and heart
failure (53). There are various methods to assess BRS. For patients
with schizophrenia, the non-invasive sequence method is used
(54). Here, spontaneous sequences of at least three consecutive
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beats are analyzed, when an increased systolic blood pressure
(SBP) of at least 1mmHg causes an increased BBI of at least 5ms
(bradycardic sequence) or a decreased SBP causes a decreased BBI
(tachycardic sequence). For each sequence, the regression between
the three SBP values and three BBI values is calculated and the
slope (tachycardic slope: tslope; bradycardic slope: bslope) of the
regression line is used as an index of BRS.
Studies in unmedicated patients with schizophrenia show sig-
nificantly reduced tachycardic and bradycardic slopes (31, 35,
55, 56). Thus, the fine-tuning of blood pressure and heart rate
is severely impaired among acute psychotic patients. Interest-
ingly, blood pressure values and blood pressure variability are
only marginally altered in these patients (57). We have therefore
concluded that the primary change in patients is observed in the
heart rate domain. To explain putative mechanisms for reduced
BRS in patients, it is important to realize that powerful negative
feedback loops between heart rate and blood pressure can be
inhibited to allow the organism to adjust to demanding environ-
mental strains (inhibition of baroreflex vagal bradycardia, BVB).
Thus, BRS has been shown to decrease during specific cognitive
demands, such as basic arithmetic operations (58) or physical
activity (59). Thus, this might imply that the decrease of efferent
vagal activity and the inhibition of BVB in acute schizophrenia
are actually caused by stress due to psychotic experiences or
the psychosis itself, a process that allows the organism under
physiological conditions to adjust to demanding environmental
strains.
Patients Breathing Rates
During acute episodes, a putative relation between breathing rates
and symptom severity were described in patients with schizophre-
nia 80 years ago (38, 60–63). The German Psychiatrist Wittkower
described the breathing rate in psychotic patients to be faster and
more regular. In our analysis, we found that a fast breathing rate
is the dominant feature in unmedicated patients and that it is
accompanied by some shallowness of breathing. We also found
more variability within the breathing pattern (38). However, the
minute ventilation is not altered in patients. Interestingly, when
healthy subjects breathe in the modus of patients, we observed
increased heart rates and reduced variability (unpublished data).
Healthy relatives of patients do not show changes within their
breathing pattern (38). We speculate that the breathing pattern is
closely associated with symptoms during acute episodes, while the
HRV pattern seems to be a trait marker. Of course, it is impossible
to disentangle breathing and HRV completely because of their
close interrelationship.
Exercise and Autonomic Function
Cardiorespiratory fitness is a strong and independent mortality
predictor for humans (64). Therefore, it is important to inves-
tigate fitness in patients with schizophrenia, since it might be
one approach for modifying the increased cardiac mortality risk
associated with the disease. Overall, reduced physical fitness is a
commonly reported trait among patients with schizophrenia that
can be improved by means of physical interventional studies (16,
65, 66). Ostermann et al. (67) investigated autonomic function
during physical exercise. Interestingly, they showed increased
breathing rates and reduced vagal modulation during the entire
test. However, heart rates were only initially increased in com-
parison to controls. The authors reported that reduced vagal
function during the exercise test correlated with the inflamma-
tory response after exercise as assessed by TNFalpha levels. This
result touches on a further important relationship between vagal
modulation and inflammatory response (68). Most interestingly,
in a new study, Herbsleb et al. (16) show that chronotropic
incompetence (CI), which is a strong predictor for cardiovascular
mortality, is reported in about 60% of patients with schizophre-
nia taking regular medication. CI is defined as the inability
of the heart to increase its rate commensurate with increased
activity or demand. It has been established as a predictor of
cardiovascular events and all-cause mortality (69). Most inter-
estingly, the authors describe similarly a lack of catecholamine
increase and a close correlation between CI and the duration
of disease. Thus, future studies need to investigate the cardio-
vascular benefit, which patients might gain due to different
types of exercise to reduce their potential cardiovascular risk
profile (16).
Psychopathology and Autonomic Function
Autonomic dysfunction is most likely the consequence of long-
lasting stressful experiences associated with the psychotic state,
in addition to a genetic underlying predisposition to autonomic
dysfunction as observed in relatives of patients. Therefore, the
notion of a relation between the severity of the disease assessed by
the global assessment of functioning scale (GAF) and autonomic
dysfunction is not surprising (70). However, it is rather inter-
esting that autonomic dysfunction seems to be somehow related
to the degree and amount of delusional states found in patients
(29, 49, 55, 56). A clear relation to negative symptoms was less
often observed (42). Altogether, there is no simple and linear
relation between the severity of a current episode and the degree
of autonomic dysfunction but some relation to the delusional
state.
Future Perspectives
There are three important areas for future research in patients
with schizophrenia. First of all, studies need to investigate the
definite relation between the degree of autonomic dysfunction
and the potential risk of cardiovascular events for these patients.
At a minimum, schizophrenic patients at increased risk should
be identified. Second, the brain activations underlying autonomic
dysfunction need to be assessed to elucidate pathophysiological
mechanisms. Third, psychiatric research is focused mainly on
mental aspects of the disease, thereby neglecting obvious physical
health needs of patients with schizophrenia. Here, a joint effort
is needed to design interventional strategies in everyday clinical
settings to improve physical health and quality of life of our
patients.
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